What is the appropriate management of hypotensive shock in a child?

Management of Hypotensive Shock in Children

In children with hypotensive shock in settings with intensive care availability, immediately administer up to 40-60 mL/kg of balanced crystalloid in 10-20 mL/kg boluses over the first hour while titrating to clinical markers of cardiac output, and initiate vasoactive therapy (epinephrine or norepinephrine preferred over dopamine) after fluid resuscitation if hypotension persists. 1

Initial Fluid Resuscitation

In Healthcare Systems WITH Intensive Care:

• Administer 40-60 mL/kg total fluid in the first hour using 10-20 mL/kg boluses 1
• Use balanced/buffered crystalloids (e.g., lactated Ringer's, Plasma-Lyte) rather than 0.9% saline 1
• Crystalloids are preferred over albumin due to equivalent outcomes and lower cost 1
• Absolutely avoid starches (strong recommendation) and avoid gelatin 1

In Healthcare Systems WITHOUT Intensive Care:

• If hypotension is present: Administer up to 40 mL/kg in boluses (10-20 mL/kg per bolus) over the first hour 1
• If hypotension is absent: Do NOT give bolus fluids; start maintenance fluids only 1

Critical Monitoring During Fluid Administration:

Stop fluid boluses immediately if signs of fluid overload develop:

• Pulmonary edema (rales, increased work of breathing, hypoxemia)
• New or worsening hepatomegaly 1

Titrate fluids to these clinical markers of cardiac output:

• Heart rate normalization
• Blood pressure improvement
• Capillary refill time <2 seconds
• Improved level of consciousness
• Urine output >1 mL/kg/hr
• Serial lactate clearance 1

Vasoactive Therapy

Initiate vasoactive agents after 40-60 mL/kg of fluid if hypotension persists with evidence of abnormal perfusion. 1

First-Line Vasoactive Agents:

While guidelines could not recommend a specific first-line agent 1, the evidence supports:

• Epinephrine OR norepinephrine are preferred over dopamine 1
• Both have weak recommendations but are superior to dopamine in pediatric septic shock
• Dopamine should only be used in hypotensive patients with bradycardia or low risk for tachycardia 2

Practical Considerations for Vasoactive Administration:

• Can be initiated through peripheral IV or intraosseous access if central venous access is not readily available 1
• This is critical in emergency settings where delays in obtaining central access should not prevent vasoactive therapy
• Dopamine may be substituted as first-line if epinephrine/norepinephrine are not readily available 1

Tailoring Therapy to Shock Physiology:

The hemodynamic state in pediatric shock is heterogeneous and changes over time 3:

• Low cardiac output (58% of cases): Responds to inotropic therapy ± vasodilator 3
• High cardiac output with low SVR (20%): Responds to vasopressor therapy alone 3
• Mixed cardiac and vascular dysfunction (22%): Requires combined vasopressor and inotropic therapy 3

Key pitfall: Children with fluid-refractory shock are frequently hypodynamic (unlike adults) and may require inotrope and vasodilator therapy rather than pure vasopressors 3. If shock persists despite therapy, suspect incorrect cardiovascular therapeutic regimen and reassess hemodynamic state 3.

Hemodynamic Monitoring and Targets

Blood Pressure Targets:

• Target MAP at least at the 10th percentile for age as a pragmatic threshold 4
• While guidelines could not specify 5th vs 50th percentile targets 1, the 10th percentile balances hypoperfusion risk against overtreatment 4
• Hypotension is a late sign of decompensated shock and associated with increased mortality 4

Multimodal Assessment:

• Use advanced hemodynamic variables when available (cardiac output/index, SVR, ScvO2) in addition to clinical variables 1
• Trend lactate levels to guide resuscitation; persistent elevation indicates incomplete hemodynamic resuscitation 1
• Do NOT use bedside clinical signs alone to categorize shock as "warm" or "cold" 1
• Point-of-care echocardiography is essential for early, repeated assessment 4

Source Control and Antimicrobials

• Implement emergent source control as soon as infection amenable to intervention is identified 1
• Remove intravascular devices confirmed as infection source after establishing alternative access 1
• Use empiric multi-drug antimicrobial therapy when septic shock is present/suspected 1
• Optimize antimicrobial dosing based on pharmacokinetic/pharmacodynamic principles 1
• Daily assessment for de-escalation after first 48 hours guided by microbiology and clinical improvement 1

Common Pitfalls to Avoid

1. Delaying vasoactive therapy while attempting central line placement—use peripheral/IO access 1
2. Continuing fluid boluses despite signs of fluid overload (pulmonary edema, hepatomegaly) 1
3. Using dopamine as first-line instead of epinephrine/norepinephrine 1
4. Assuming all pediatric shock is hyperdynamic—many children are hypodynamic and need inotropes 3
5. Not reassessing hemodynamic state when shock persists—the physiology changes over time 3
6. Relying on blood pressure alone—integrate lactate, urine output, mental status, and capillary refill 1